[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-337683-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-337683-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","long-non-coding-rna-sox2ot-in-tamoxifen-resistant-breast-cancer","Long non-coding RNA SOX2OT in tamoxifen- resistant breast cancer","","Hormone receptor (HR)-positive breast cancer can become aggressive after developing hormone-treatment resistance. This study clarifies the role of long non-coding RNA (lncRNA) SOX2OT in tamoxifen-resistant (TAMR) breast cancer and examines its potential links with the tumor microenvironment (TME). TAMR-V and TAMR-H cells were compared with MCF-7, using next-generation sequencing, lncRNA profiling, and RT-qPCR to assess expression, plus assays for proliferation, migration, and invasion, and Kaplan–Meier outcome analysis.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/long-non-coding-rna-sox2ot-in-tamoxifen-resistant-breast-cancer/337683/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/long-non-coding-rna-sox2ot-in-tamoxifen-resistant-breast-cancer/337683.png","ImageObject",300,407,{"name":42,"@type":43},"Emma Wilson","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main focus of the study?","Question",{"text":63,"@type":64},"The study investigates how the lncRNA SOX2OT contributes to tamoxifen-resistant (TAMR) breast cancer and explores its potential interaction with the tumor microenvironment (TME).","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was SOX2OT expression evaluated in TAMR models?",{"text":68,"@type":64},"SOX2OT expression was assessed using next-generation sequencing, RNA extraction with lncRNA profiling, and quantitative RT-qPCR.",{"name":70,"@type":61,"acceptedAnswer":71},"What effects did SOX2OT overexpression have on TAMR cells?",{"text":72,"@type":64},"SOX2OT overexpression increased cell proliferation and cell invasion in TAMR cells, while also showing no significant alteration of SOX2 levels, suggesting an interaction independent of SOX2 abundance.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},337683,1790539926,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},3848291630094,"https://eur-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Lee et al. BMC Molecular and Cell Biology (2024) 25:12  \n[https://doi.org/10.1186/s12860-024-00510-y](https://doi.org/10.1186/s12860-024-00510-y)  \nBMC Molecular and Cell Biology  \nRESEARCH Open Access  \nLong non-coding RNA SOX2OT in tamoxifen- resistant breast cancer  \nJeeyeon Lee 1,5, Eun-Ae Kim2, Jieun Kang5, Yee Soo Chae3,5, Ho Yong Park 1,5, Byeongju Kang 1,5, Soo Jung Lee3,5, In Hee Lee3,5, Ji-Young Park4,5, Nora Jee-young Park4,5 and Jin Hyang Jung 1,5*  \nAbstract  \nHormone receptor (HR)-positive breast cancer can become aggressive after developing hormone-treatment resistance. This study elucidated the role of long non-coding RNA (lncRNA) SOX2OT in tamoxifen-resistant (TAMR) breast cancer and its potential interplay with the tumor microenvironment (TME) . TAMR breast cancer cell lines TAMR-V and TAMR-H were compared with the luminal type A cell line (MCF-7) . LncRNA expression was assessed via next-generation sequencing, RNA extraction, lncRNA profiling, and quantitative RT-qPCR. SOX2OT overexpression effects on cell proliferation, migration, and invasion were evaluated using various assays. SOX2OT was consistently downregulated in TAMR cell lines and TAMR breast cancer tissue. Overexpression of SOX2OT in TAMR cells increased cell proliferation and cell invasion. However, SOX2OT overexpression did not significantly alter SOX2 levels, suggesting an independent interaction within TAMR cells. Kaplan–Meier plot analysis revealed an inverse relationship between SOX2OT expression and prognosis in luminal A and B breast cancers. Our findings highlight the potential role of SOX2OT in TAMR breast cancer progression. The downregulation of SOX2OT in TAMR breast cancer indicates its involvement in resistance mechanisms. Further studies should explore the intricate interactions between SOX2OT, SOX2, and TME in breast cancer subtypes.  \nKeywords Breast cancer, Tamoxifen, Resistance, LncRNA, SOX2OT  \n*Correspondence:  \nJin Hyang Jung  \n[jjh01@knu.ac.kr](jjh01@knu.ac.kr)  \n1Department of Surgery, School of Medicine, Kyungpook National University, Daegu, Republic of Korea  \n2Cell & Matrix Research Institute, Kyungpook National University, Daegu, Republic of Korea  \n3Department of Oncology/Hematology, School of Medicine, Kyungpook National University, Daegu, Republic of Korea  \n4Department of Pathology, School of Medicine, Kyungpook National University, Daegu, Republic of Korea  \n5Kyungpook National University Chilgok Hospital, Hoguk-ro 807, Buk-gu, 41404 Daegu, Republic of Korea  \nIntroduction  \nHormone receptor (HR)-positive breast cancer constitutes a prevalent subtype characterized by the presence of estrogen receptor (ER) and/or progesterone receptor (PR) positive cells, enabling hormonal stimulation of cancer growth [1, 2]. HR-positive breast cancer accounts for approximately 60–70% of cases and treatment primarily relies on hormone therapy, including drugs like tamoxifen and aromatase inhibitors, with targeted therapies such as CDK4/6 inhibitors sometimes used [3, 4]. HRpositive breast cancer is generally associated with a better prognosis than triple-negative breast cancer (TNBC) or HER2-positive breast cancer [5–7]. This subtype can be managed with hormone treatments that either suppress hormones or inhibit HRs [8–10]. However, not all breast cancer cells may respond consistently, and those  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use","cbCaie7zNaYUzMrw","https://ap.wps.com/l/cbCaie7zNaYUzMrw","pdf",2713791,11,"English","# Abstract\n# Introduction\n# Materials and Methods\n# Results\n# Discussion\n# Conclusion","[{\"question\":\"What is the main focus of the study?\",\"answer\":\"The study investigates how the lncRNA SOX2OT contributes to tamoxifen-resistant (TAMR) breast cancer and explores its potential interaction with the tumor microenvironment (TME).\"},{\"question\":\"How was SOX2OT expression evaluated in TAMR models?\",\"answer\":\"SOX2OT expression was assessed using next-generation sequencing, RNA extraction with lncRNA profiling, and quantitative RT-qPCR.\"},{\"question\":\"What effects did SOX2OT overexpression have on TAMR cells?\",\"answer\":\"SOX2OT overexpression increased cell proliferation and cell invasion in TAMR cells, while also showing no significant alteration of SOX2 levels, suggesting an interaction independent of SOX2 abundance.\"}]","Long non-coding RNA SOX2OT in tamoxifen- resistant breast cancer | PDF",1790020113,28,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d8aad92e34c2210069e6a519c058d975.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c5e9ca9724e2500aa0fb23c514900a92.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6c0d3cd74a2ef07a866139e96d3ae45e.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0b27961f414031c6e0b0ec284cc3b4d6.webp",980,1306]